Titre:
  • Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
Auteur:Praga, Claudio; Bergh, Jonas; Bliss, Judith; Bonneterre, J; Cesana, Bruno; Coombes, R Charles; Fargeot, Pierre; Folin, Annika; Fumoleau, Pierre; Giuliani, Rosa; Kerbrat, Pierre; Hery, Michel; Nilsson, Jonas; Onida, Francesco; Piccart-Gebhart, Martine; Shepherd, L; Therasse, P.; Wils, J; Rogers, David
Informations sur la publication:Journal of clinical oncology, 23, 18, page (4179-4191)
Statut de publication:Publié, 2005-06
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant -- adverse effects
Cyclophosphamide -- adverse effects
Cyclophosphamide -- therapeutic use
Data Interpretation, Statistical
Epirubicin -- adverse effects
Epirubicin -- therapeutic use
Female
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute -- chemically induced
Middle Aged
Myelodysplastic Syndromes -- chemically induced
Randomized Controlled Trials as Topic
Risk Factors
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2005.05.029
info:pii/23/18/4179
info:pmid/15961765